Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Wireless, Fully Implantable LVAD System to Make Life Easier for Heart Failure Patients

By HospiMedica International staff writers
Posted on 14 Nov 2024

Left Ventricular Assist Devices (LVADs) have traditionally relied on physical drivelines to provide power, creating a connection through the patient's skin. These drivelines increase the risk of infections and complications, as the open passageway can allow pathogens to enter. Now, new research is exploring a groundbreaking approach to powering LVADs wirelessly, offering a potential solution to this significant limitation of current LVAD technology. The development of a fully implantable, wireless LVAD system could greatly reduce these risks, enhance patient comfort, and improve overall safety.

Researchers at SUNY Polytechnic Institute (Utica, NY, USA), in association with other experts, have pioneered a new method to wirelessly power LVADs using an ultrasound transcutaneous energy transmission (UTET) system. This system employs ultrasonic waves to transmit energy across the skin, eliminating the need for traditional drivelines. The innovative system could reduce infection risks and simplify life for heart failure patients. The research, published in Cardiovascular Engineering and Technology, demonstrated that the UTET system could effectively wirelessly power LVADs in laboratory and animal models, operating across a range of flow and speed settings.

To ensure safety, critical parameters such as tissue temperature were closely monitored to prevent overheating. In addition to power transmission, the UTET system facilitated real-time data communication, allowing for pump control, which is essential for maintaining patient safety and device functionality. The wireless capabilities of the UTET system represent a significant step toward fully implantable LVADs, potentially improving the quality of life and safety for patients who rely on mechanical circulatory support. This research also lays the groundwork for the development of other implantable medical devices that could operate without external power sources, expanding the possibilities for transcutaneous energy transmission systems.

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Surgical Positioning Accessory
Lateral Support Curved Short (10-360)
New
Auditory Evoked Potential Device
Bio-logic NavPRO ONE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get complete access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.